Editorial Team

The management of our journal is a collaborative endeavor by the whole editorial team, featuring an active, widely respected, diverse, and representative Editorial Board. The editorial structure of the journal is listed as below and the roles and responsibilities of the editorial team are available at: https://www.amegroups.com/pages/journal-management#content-title.

Editor-in-Chief

Mark Roschewski, MD

Senior Clinician, Lymphoid Malignancies Branch, Center for Cancer Research, Bethesda, MD, USA

Editorial Board

Francesco Bertoni

Head, Lymphoma Genomics Deputy director, Institute of Oncology Research, Faculty of Biomedical Sciences, Università della Svizzera italiana (USI), Bellinzona, Switzerland Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland

Teresa Calimeri, MD PhD

Senior Clinician, Lymphoma Unit, IRCCS San Raffaele Hospital, Milan, Italy

James R. Cerhan, MD, PhD

Professor of Epidemiology and the Ralph S. and Beverly Caulkins Professor of Cancer Research, Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA

Dai Chihara

Assistant Professor, MD Anderson Cancer Center, Houston, TX, USA

Jonathon B. Cohen, MD, MS

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA

Tarec Christoffer El-Galaly, MD, DMSc

Professor of Hematology, Consultant Hematologist, Aalborg University, Aalborg University Hospital, Aalborg, Denmark

Andrés J. M. Ferreri

IRCCS San Raffaele Scientific Institute, Milano, Italy

Jonathan W. Friedberg, MD

Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA

Lasse Hjort Jakobsen, PhD

Biostatistician, Aalborg University, Aalborg University Hospital, Aalborg Denmark

Daniel J. Landsburg, MD

Associate Professor of Clinical Medicine, Department of Medicine, University of Pennsylvania

Jennifer K. Lue, MD

Assistant Member, Lymphoma Service, Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center

Stefano Luminari, MD

Full PROFESSOR MEDICAL ONCOLOGY, University of Modena and Reggio Emilia. Head of the unit for “Clinical research in onco-hematology” at the Hematology Division, AUSL IRCCS, Reggio Emilia.

Matthew J. Maurer, MS

Statistician III, Division of Biomedical Statistics and Informatics; Assistant Professor of Biostatistics and Medicine, Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester MN, USA

Nicolas Martinez-Calle, MD, PhD

Lymphoma clinician, CLL and CART clinical lead. Nottingham University Hospitals, NHS trust, UK

Davide Rossi, MD, PhD

Institute of Oncology Research, Switzerland

Laurie H. Sehn, MD, MPH

Clinical Professor, British Columbia Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, Canada

John Seymour, MD, PhD

Integrated Department of Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia

Julie M. Vose, MD, MBA

Neumann M. and Mildred E. Harris Professor of Internal Medicine; Chief, Division of Oncology and Hematology, University of Nebraska Medical Center, Omaha, NE, USA

Emanuele Zucca, MD

Oncology Institute of Southern Switzerland; Institute of Oncology Research, Bellinzona, Switzerland